Total Funding
22
45
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
192630
Belluscura is a medical device company that focused on novel oxygen-based treatment platforms.
Robert Rauker: CEOPast Role: Acacia Research, Vice President , Licensing and New Business Development- Simon Neicheril: Chief Financial Officer
About the Company
Belluscura is a medical device company that focused on novel oxygen-based treatment platforms. They are a license and develop proprietary technologies that can be applied across a range of treatment possibilities. Belluscura is focused on disruptive treatment platforms so that their technology can be adapted and applied in a wide range of markets
beyond those traditionally applied to a single product or product line.
Belluscura was founded in 2015 and is based in London, Farringdon.
